Key result
Cancer links to reduced platelet apoptosis and increased Akt activation, contributing to elevated platelet counts.
Why the study?
The cause of high platelet counts in cancer patients was not fully understood, particularly the role of platelet apoptosis and Akt pathway activation.
Observational
Activation of the Akt pathway by tumor-platelet crosstalk reduces platelet apoptosis, contributing to elevated platelet counts in cancer patients.
Answers are grounded in this paper and cite their sources.
Altered platelet indices may aid breast cancer prognostication; hypothesis-generating and requires prospective validation before clinical use.
Platelets counts increase in various cancer patients, which is associated with poor prognosis. However, the cause of high platelet counts in cancer patients is still not fully understood. Here we demonstrated that compared with healthy controls, there were significant differences in platelet parameters, mean platelet volume (MPV), platelet distribution width (PDW), platelet larger cell ratio (P-LCR), and platelet crit (PCT), reflecting platelet volume in breast cancer patients by clinical retrospective analysis. The mitochondrial transmembrane potential (ΔΨm) depolarization and phosphatidylserine (PS) externalization declined, accompanied by reduced expression of pro-apoptotic factors Bak, Bax and apoptotic executor caspase-3, and elevated of anti-apoptotic factor Bcl-xl in various cancer patients' platelets. Notably, the phosphorylation level of Akt and its downstream target Bad increased in platelets from cancer patients. MK2206, the inhibitor of Akt, reduced the phosphorylation level of Akt and Bad, and induced apoptosis of platelets. When platelets from healthy controls cocultured with the cultural supernatant of cancer cells, the phosphorylation level of Akt and Bad in the platelets was elevated and the cultural supernatant of cancer cells could rescue the apoptosis of platelet induced by MK2206. Therefore, in our study the apoptosis of platelets in cancer patients was declined, which exerted an influence on the rise of platelet counts in breast cancer patients. The cross-talking between tumor and platelets could affect platelet apoptosis by regulating Akt signaling pathway in platelets.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2022) conducted an observational in Solid tumors / breast cancer. Cancer vs. Healthy controls was evaluated on Platelet parameters and apoptosis. Platelets from cancer patients exhibited reduced apoptosis and increased Akt pathway activation compared to healthy controls, contributing to elevated platelet counts.
Synapse has enriched 10 related papers. Consider them for comparative context: